Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
Rival PCSK9 Makers Cut Prices to Get Approval from UK Health Service
Even though prices for both drugs in Britain was less than half the list price in the United States, NICE demanded further discounts before issuing a draft guidance that the therapies were appropriate for those who cannot otherwise lower cholesterol.
Deaths From Hepatitis C Virus Hit All-Time High, CDC Reports
CDC also published a separate study that found more people in the United States now die from hepatitis C than die from HIV or any other infectious disease. The report comes as The American Journal of Managed Care publishes a special issue on policy concerns over patient access to new therapies that cure HCV.
Reports of Coverage Snags Emerge Among Iowa Medicaid Managed Care Clients
Early reports to the state's largest newspaper resemble tales from the days of Medicaid transitions in other states. While managed care may be better for accountability measures over the long haul, in state after state, large-scale transitions prove difficult.
Phase 3 Trial Results Raise Hopes That Islet Transplants Could Soon Treat Type 1 Diabetes
The results, published in Diabetes Care, move the hope of pancreatic cell islet transplants close to commercialization, which would bring the technique to more patients who cannot produce their own insulin.